Pietka Terri A, Morris Edward F, Basco Megan, Shew Jennifer, Son Ni-Huiping, Liu Zhenxiu, Davies Brandon A, Goldberg Ira J, Crewe Clair, Abumrad Nada A
Department of Medicine, Division of Nutritional Sciences and Obesity Research, Washington University School of Medicine, St Louis, MO, USA.
Department of Medicine, Holman Division of Endocrinology Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, USA.
bioRxiv. 2025 Aug 1:2025.07.31.665751. doi: 10.1101/2025.07.31.665751.
Lipoprotein lipase (LPL) is critical for clearance of circulating triglycerides and for tissue fatty acid supply. LPL is primarily synthesized and secreted by adipocytes into the interstitium and must traffic from there to the abluminal/basolateral side of capillary endothelial cells. There, LPL binds glycosylphosphatidylinositol-anchored protein 1, GPIHBP1, which stabilizes the protein and facilitates its movement across the endothelial cells to the luminal side where it functions in hydrolysis of lipoprotein triglycerides. Importance of LPL traffic is supported by findings that rare mutations in GPIHBP1 cause hypertriglyceridemia. However our understanding of how LPL is secreted by adipocytes and traffics to endothelial cells is incomplete. Here we examined the possibility that secretion and traffic of adipocyte LPL might involve generation of small extracellular vesicles (sEVs/exosomes) which often mediate cell-cell communication. Proteomic analysis of sEVs secreted by adipocytes showed them enriched in LPL. To study LPL secretion and transfer we generated human derived pre-adipocytes (HPA) that stably express tagged LPL (FLAG and His epitopes). LPL pulldown and sEV isolation from HPA conditioned media documented that greater than 70% of secreted LPL is present in sEVs. The mechanism for LPL secretion in sEVs was found to involve the ESCRT-independent neutral sphingomyelinase 2 (nSMase2) pathway, as treatment with the nSMase2 inhibitor GW4869 reduced secretion by 80%. The above observations were reproduced using highly sensitive nanoparticle flow cytometry. The sEV associated LPL has lipolytic activity and it is released by heparin addition indicating it is on the sEV surface. In addition, using human derived microvascular endothelial cells with stable lentiviral expression of GPIHBP1 we show that LPL positive sEVs transfer LPL to these cells, but not to control cells without GPIHBP1. Our findings suggest that sEV formation by nSMase2 controls adipocyte LPL secretion and traffic, that sEVs protect LPL activity and facilitate LPL transfer to GPIHBP1 on endothelial cells.
脂蛋白脂肪酶(LPL)对于循环甘油三酯的清除以及组织脂肪酸供应至关重要。LPL主要由脂肪细胞合成并分泌到间质中,且必须从那里转运到毛细血管内皮细胞的腔外/基底外侧。在那里,LPL与糖基磷脂酰肌醇锚定蛋白1(GPIHBP1)结合,GPIHBP1可稳定该蛋白,并促进其穿过内皮细胞向管腔侧移动,在管腔侧LPL发挥水解脂蛋白甘油三酯的作用。GPIHBP1的罕见突变会导致高甘油三酯血症,这一发现支持了LPL转运的重要性。然而,我们对LPL如何由脂肪细胞分泌并转运至内皮细胞的理解并不完整。在此,我们研究了脂肪细胞LPL的分泌和转运可能涉及小细胞外囊泡(sEVs/外泌体)生成的可能性,小细胞外囊泡通常介导细胞间通讯。对脂肪细胞分泌的sEVs进行蛋白质组学分析发现,它们富含LPL。为了研究LPL的分泌和转移,我们构建了稳定表达带标签LPL(FLAG和His表位)的人源前脂肪细胞(HPA)。从HPA条件培养基中进行LPL沉淀和sEV分离证明,超过70%的分泌型LPL存在于sEVs中。发现sEVs中LPL的分泌机制涉及不依赖于内体分选转运复合体(ESCRT)的中性鞘磷脂酶2(nSMase2)途径,因为用nSMase2抑制剂GW4869处理可使分泌减少80%。使用高灵敏度纳米颗粒流式细胞术重现了上述观察结果。与sEV相关的LPL具有脂解活性,并且肝素可使其释放,这表明它位于sEV表面。此外,使用稳定慢病毒表达GPIHBP1的人源微血管内皮细胞,我们发现LPL阳性sEVs将LPL转移至这些细胞,但不转移至没有GPIHBP1的对照细胞。我们的研究结果表明,nSMase2介导的sEV形成控制脂肪细胞LPL的分泌和转运,sEVs保护LPL活性并促进LPL向内皮细胞上的GPIHBP1转移。